Arkolith/Insider Trading/GLS/Form 4

Leider Harry L.

Chief Medical OfficerGELESIS HOLDINGS, INC. (GLS) · full profile →Form 4 · filed May 9, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2022Grant(A)34K——44K
May 6, 2022Grant(A)270K——314K
May 6, 2022Grant(A)10K——10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 6, 2022Grant(A)270K—$0270K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-057537) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML